Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
NKGen Biotech Inc a clinicalstage biotechnology company focused on the development and commercialization of innovative autologous allogeneic and CARNK natural killer cell therapeutics
Elpiscience Biopharma Ltd and Astellas Pharma Inc today announced a research collaboration and license agreement for novel bispecific macrophage engagers ES and another program The two companies will collaboratively
Immunome Inc a biotechnology company focused on developing firstinclass and bestinclass targeted cancer therapies today announced that it entered into a definitive asset purchase agreement with Atreca
Gracell Biotechnologies Inc a global clinicalstage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases
Senti Biosciences Inc a clinical stage biotechnology company developing nextgeneration cell and gene therapies using its proprietary Gene Circuit platform today announced that it received clearance
Amylyx Pharmaceuticals Inc today announced that the first participant has been dosed in ORION a randomized doubleblind placebocontrolled Phase clinical trial of AMX
Astellas Pharma Inc announced today that it has completed the acquisition of Propella Therapeutics Inc and has become a wholly owned subsidiary of Astellas as of US Eastern Time Through the acquisition of Propella Astellas has acquired PRL
BioLineRx Ltd a commercial stage biopharmaceutical company pursuing lifechanging therapies in oncology and rare diseases today announced that the first patient has been dosed in the Phase clinical trial
SciTech Development a clinicalstage pharmaceutical company with a novel and patented drug delivery platform today announced that the company has dosed the first patient in its Phase clinical trial with lead cancer drug candidate
IAMA Therapeutics a pharmaceutical company focused on the discovery development and commercialization of novel medicines for children affected by brain disorders today announced that the Italian Medicines Agency
